A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine
Highlights • Distress tolerance (DT) participants had high rates of session attendance, demonstrating feasibility. • DT participants had lower rates of opioid use at all follow-up assessments vs health education (HE). • Rates of buprenorphine dropout were 24% and 25% in the HE and DT arms, respectiv...
Gespeichert in:
| Veröffentlicht in: | Drug and alcohol dependence 2015-02, Vol.147, p.243-250 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 250 |
|---|---|
| container_issue | |
| container_start_page | 243 |
| container_title | Drug and alcohol dependence |
| container_volume | 147 |
| creator | Stein, Michael D Herman, Debra S Moitra, Ethan Hecht, Jacki Lopez, Rosalie Anderson, Bradley J Brown, Richard A |
| description | Highlights • Distress tolerance (DT) participants had high rates of session attendance, demonstrating feasibility. • DT participants had lower rates of opioid use at all follow-up assessments vs health education (HE). • Rates of buprenorphine dropout were 24% and 25% in the HE and DT arms, respectively. |
| doi_str_mv | 10.1016/j.drugalcdep.2014.11.007 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4297723</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S037687161401919X</els_id><sourcerecordid>1660403788</sourcerecordid><originalsourceid>FETCH-LOGICAL-c637t-27804662b7ba217c70edc23efc974797f548b1eb7e996f9f9590d843414d98003</originalsourceid><addsrcrecordid>eNqNkk1vFSEUhonR2Gv1LxiWbu4UZrgwbJrURq1JExdq4o4wcOaWKwMjME3qzn8uk1vrx0o2EM57Pp-DEKakoYTys0Nj07LX3liYm5ZQ1lDaECIeoQ3thdwSwvhjtCGd4NteUH6CnuV8IPVwSZ6ik3a3o6QjYoN-XOA5gXeTCzrd4aSDjZP7DhabGEqK3tdnSU57HEessXW5JMgZl-ihqg1UK-gyQSh4jAnH2UVncS0Mgl0_Z0g5hoxdcMXp4sIeD0vNGWKab1yA5-jJqH2GF_f3Kfr89s2ny6vt9Yd37y8vrreGd6JsW9HXpng7iEG3VBhBwJq2g9FIwYQU4471A4VBgJR8lKPcSWJ71jHKrOwJ6U7R-THuvAxT9a21Je3VnNxUO1dRO_W3JbgbtY-3irVSiLarAV7dB0jx2wK5qMllA97rAHHJinJOWB1531dpf5SaFHNOMD6koUStBNVB_SaoVoKKUlUJVteXf5b54PgLWRW8PgqgDuvWQVLZOKggrEtgirLR_U-W83-CGF8BGe2_wh3kQ1xSqDAUVblVRH1cN2ldJMoIlVR-6X4Cu0vLXQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1660403788</pqid></control><display><type>article</type><title>A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Stein, Michael D ; Herman, Debra S ; Moitra, Ethan ; Hecht, Jacki ; Lopez, Rosalie ; Anderson, Bradley J ; Brown, Richard A</creator><creatorcontrib>Stein, Michael D ; Herman, Debra S ; Moitra, Ethan ; Hecht, Jacki ; Lopez, Rosalie ; Anderson, Bradley J ; Brown, Richard A</creatorcontrib><description>Highlights • Distress tolerance (DT) participants had high rates of session attendance, demonstrating feasibility. • DT participants had lower rates of opioid use at all follow-up assessments vs health education (HE). • Rates of buprenorphine dropout were 24% and 25% in the HE and DT arms, respectively.</description><identifier>ISSN: 0376-8716</identifier><identifier>EISSN: 1879-0046</identifier><identifier>DOI: 10.1016/j.drugalcdep.2014.11.007</identifier><identifier>PMID: 25510307</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Acceptance and Commitment Therapy ; Adult ; Ambulatory Care ; Buprenorphine ; Buprenorphine - therapeutic use ; Combined Modality Therapy - methods ; Distress ; Female ; Humans ; Implosive Therapy ; Male ; Narcotic Antagonists - therapeutic use ; Opiate Substitution Treatment - methods ; Opioid ; Opioid-Related Disorders - drug therapy ; Opioid-Related Disorders - therapy ; Outpatients ; Psychiatry ; Recurrence ; Relapse ; Treatment Outcome ; Trial registered at clinicaltrials.org. Trial number NCT01556087</subject><ispartof>Drug and alcohol dependence, 2015-02, Vol.147, p.243-250</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2014 Elsevier Ireland Ltd</rights><rights>Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.</rights><rights>2014 Elsevier Ltd. All rights reserved. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c637t-27804662b7ba217c70edc23efc974797f548b1eb7e996f9f9590d843414d98003</citedby><cites>FETCH-LOGICAL-c637t-27804662b7ba217c70edc23efc974797f548b1eb7e996f9f9590d843414d98003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.drugalcdep.2014.11.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25510307$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stein, Michael D</creatorcontrib><creatorcontrib>Herman, Debra S</creatorcontrib><creatorcontrib>Moitra, Ethan</creatorcontrib><creatorcontrib>Hecht, Jacki</creatorcontrib><creatorcontrib>Lopez, Rosalie</creatorcontrib><creatorcontrib>Anderson, Bradley J</creatorcontrib><creatorcontrib>Brown, Richard A</creatorcontrib><title>A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine</title><title>Drug and alcohol dependence</title><addtitle>Drug Alcohol Depend</addtitle><description>Highlights • Distress tolerance (DT) participants had high rates of session attendance, demonstrating feasibility. • DT participants had lower rates of opioid use at all follow-up assessments vs health education (HE). • Rates of buprenorphine dropout were 24% and 25% in the HE and DT arms, respectively.</description><subject>Acceptance and Commitment Therapy</subject><subject>Adult</subject><subject>Ambulatory Care</subject><subject>Buprenorphine</subject><subject>Buprenorphine - therapeutic use</subject><subject>Combined Modality Therapy - methods</subject><subject>Distress</subject><subject>Female</subject><subject>Humans</subject><subject>Implosive Therapy</subject><subject>Male</subject><subject>Narcotic Antagonists - therapeutic use</subject><subject>Opiate Substitution Treatment - methods</subject><subject>Opioid</subject><subject>Opioid-Related Disorders - drug therapy</subject><subject>Opioid-Related Disorders - therapy</subject><subject>Outpatients</subject><subject>Psychiatry</subject><subject>Recurrence</subject><subject>Relapse</subject><subject>Treatment Outcome</subject><subject>Trial registered at clinicaltrials.org. Trial number NCT01556087</subject><issn>0376-8716</issn><issn>1879-0046</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk1vFSEUhonR2Gv1LxiWbu4UZrgwbJrURq1JExdq4o4wcOaWKwMjME3qzn8uk1vrx0o2EM57Pp-DEKakoYTys0Nj07LX3liYm5ZQ1lDaECIeoQ3thdwSwvhjtCGd4NteUH6CnuV8IPVwSZ6ik3a3o6QjYoN-XOA5gXeTCzrd4aSDjZP7DhabGEqK3tdnSU57HEessXW5JMgZl-ihqg1UK-gyQSh4jAnH2UVncS0Mgl0_Z0g5hoxdcMXp4sIeD0vNGWKab1yA5-jJqH2GF_f3Kfr89s2ny6vt9Yd37y8vrreGd6JsW9HXpng7iEG3VBhBwJq2g9FIwYQU4471A4VBgJR8lKPcSWJ71jHKrOwJ6U7R-THuvAxT9a21Je3VnNxUO1dRO_W3JbgbtY-3irVSiLarAV7dB0jx2wK5qMllA97rAHHJinJOWB1531dpf5SaFHNOMD6koUStBNVB_SaoVoKKUlUJVteXf5b54PgLWRW8PgqgDuvWQVLZOKggrEtgirLR_U-W83-CGF8BGe2_wh3kQ1xSqDAUVblVRH1cN2ldJMoIlVR-6X4Cu0vLXQ</recordid><startdate>20150201</startdate><enddate>20150201</enddate><creator>Stein, Michael D</creator><creator>Herman, Debra S</creator><creator>Moitra, Ethan</creator><creator>Hecht, Jacki</creator><creator>Lopez, Rosalie</creator><creator>Anderson, Bradley J</creator><creator>Brown, Richard A</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20150201</creationdate><title>A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine</title><author>Stein, Michael D ; Herman, Debra S ; Moitra, Ethan ; Hecht, Jacki ; Lopez, Rosalie ; Anderson, Bradley J ; Brown, Richard A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c637t-27804662b7ba217c70edc23efc974797f548b1eb7e996f9f9590d843414d98003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acceptance and Commitment Therapy</topic><topic>Adult</topic><topic>Ambulatory Care</topic><topic>Buprenorphine</topic><topic>Buprenorphine - therapeutic use</topic><topic>Combined Modality Therapy - methods</topic><topic>Distress</topic><topic>Female</topic><topic>Humans</topic><topic>Implosive Therapy</topic><topic>Male</topic><topic>Narcotic Antagonists - therapeutic use</topic><topic>Opiate Substitution Treatment - methods</topic><topic>Opioid</topic><topic>Opioid-Related Disorders - drug therapy</topic><topic>Opioid-Related Disorders - therapy</topic><topic>Outpatients</topic><topic>Psychiatry</topic><topic>Recurrence</topic><topic>Relapse</topic><topic>Treatment Outcome</topic><topic>Trial registered at clinicaltrials.org. Trial number NCT01556087</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stein, Michael D</creatorcontrib><creatorcontrib>Herman, Debra S</creatorcontrib><creatorcontrib>Moitra, Ethan</creatorcontrib><creatorcontrib>Hecht, Jacki</creatorcontrib><creatorcontrib>Lopez, Rosalie</creatorcontrib><creatorcontrib>Anderson, Bradley J</creatorcontrib><creatorcontrib>Brown, Richard A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Drug and alcohol dependence</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stein, Michael D</au><au>Herman, Debra S</au><au>Moitra, Ethan</au><au>Hecht, Jacki</au><au>Lopez, Rosalie</au><au>Anderson, Bradley J</au><au>Brown, Richard A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine</atitle><jtitle>Drug and alcohol dependence</jtitle><addtitle>Drug Alcohol Depend</addtitle><date>2015-02-01</date><risdate>2015</risdate><volume>147</volume><spage>243</spage><epage>250</epage><pages>243-250</pages><issn>0376-8716</issn><eissn>1879-0046</eissn><abstract>Highlights • Distress tolerance (DT) participants had high rates of session attendance, demonstrating feasibility. • DT participants had lower rates of opioid use at all follow-up assessments vs health education (HE). • Rates of buprenorphine dropout were 24% and 25% in the HE and DT arms, respectively.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>25510307</pmid><doi>10.1016/j.drugalcdep.2014.11.007</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0376-8716 |
| ispartof | Drug and alcohol dependence, 2015-02, Vol.147, p.243-250 |
| issn | 0376-8716 1879-0046 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4297723 |
| source | Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE |
| subjects | Acceptance and Commitment Therapy Adult Ambulatory Care Buprenorphine Buprenorphine - therapeutic use Combined Modality Therapy - methods Distress Female Humans Implosive Therapy Male Narcotic Antagonists - therapeutic use Opiate Substitution Treatment - methods Opioid Opioid-Related Disorders - drug therapy Opioid-Related Disorders - therapy Outpatients Psychiatry Recurrence Relapse Treatment Outcome Trial registered at clinicaltrials.org. Trial number NCT01556087 |
| title | A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T03%3A04%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20preliminary%20randomized%20controlled%20trial%20of%20a%20distress%20tolerance%20treatment%20for%20opioid%20dependent%20persons%20initiating%20buprenorphine&rft.jtitle=Drug%20and%20alcohol%20dependence&rft.au=Stein,%20Michael%20D&rft.date=2015-02-01&rft.volume=147&rft.spage=243&rft.epage=250&rft.pages=243-250&rft.issn=0376-8716&rft.eissn=1879-0046&rft_id=info:doi/10.1016/j.drugalcdep.2014.11.007&rft_dat=%3Cproquest_pubme%3E1660403788%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1660403788&rft_id=info:pmid/25510307&rft_els_id=S037687161401919X&rfr_iscdi=true |